Candel is a clinical-stage biopharma company developing off-the-shelf, multimodal immunotherapies that stimulate personalized, systemic anti-tumor responses.
We are a clinical-stage biopharma company developing off-the-shelf, multimodal immunotherapies that stimulate personalized, systemic anti-tumor responses. The Associate Director/Director, Regulatory Affairs CMC will serve as the CMC regulatory lead for one or more viral vector-based gene therapy programs.
Candel is a clinical-stage biopharma company developing off-the-shelf, multimodal immunotherapies that stimulate personalized, systemic anti-tumor responses.
Dianthus Therapeutics, Inc.